NSE: LUPIN | BSE: 500257

Mid-range Performer

Download real time

2095.70 86.00 (4.28%)

High volume today

NSE 03 Apr, 2025 3:31 PM (IST)

95,682.3

Market Cap

High in industry

0.6

Beta 1Year

Very Low volatility

Acquisition

Lupin's subsidiary acquires UK-based Renascience Pharma for Rs 135 crore See details

Lupin Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for LUPIN, BSE:500257 Lupin Ltd.

Lupin Ltd.

14 Nov 2022

2095.70

4.28%

New launches & cost optimization strategy continues to drive growth for the quarter

Hold: Lupin Ltd.

Target

KRChoksey

Lupin reported a revenue grew of 1.3% YoY (+ 10.7% QoQ) to INR 41,455 mn. The core revenue from operation grew by 2.2% YoY/ 13.5% QoQ in Q2FY23.

Lupin Ltd. is trading at high day volume of 3.3M.

Lupin Ltd.

11 Nov 2022

2095.70

4.28%

Lupin Ltd

Sell: Lupin Ltd.

Target

ICICI Direct

Lupin Ltd. is trading above all available SMAs

Lupin Ltd.

11 Nov 2022

2095.70

4.28%

US recovers; launches remain key

Sell: Lupin Ltd.

Target

ICICI Securities Limited

Lupin’s Q2FY23 performance was above our estimates with better than expected US sales. Revenue grew 1.3% YoY and 10.7% QoQ to Rs41.5bn (I-Sec: Rs39.7bn).

Number of FII/FPI investors increased from 925 to 964 in Dec 2024 qtr.

Lupin Ltd.

11 Nov 2022

2095.70

4.28%

Lupin (HOLD): Return to double-digit margins

Hold: Lupin Ltd.

Recommendation Target

BOB Capital Markets Ltd.

Q2 revenue grew 11% QoQ (+1% YoY) with recovery in US business and continued momentum in India

Lupin Ltd. is trading at high day volume of 3.3M.

Lupin Ltd.

11 Nov 2022

2095.70

4.28%

Result Update:Lupin

Hold: Lupin Ltd.

Target

Axis Direct

We expect the company to post stable margins due to improving volumes and a richer product mix. We maintain our HOLD rating on the stock with a revised TP of Rs 740/share.

Lupin Ltd. is trading above all available SMAs

Lupin Ltd.

11 Nov 2022

2095.70

4.28%

LUPIN LTD

Hold: Lupin Ltd.

Target

Prabhudas Lilladhar

Lupin Ltd.'s price crossed above 200Day SMA today

Lupin Ltd.

11 Aug 2022

2095.70

4.28%

LUPIN LIMITED

Hold: Lupin Ltd.

Target

Geojit BNP Paribas

Lupin Ltd.'s price crossed above 200Day SMA today

Lupin Ltd.

05 Aug 2022

2095.70

4.28%

Rationalisation of US portfolio impacted Q1

Sell: Lupin Ltd.

Recommendation Target

ICICI Securities Limited

Lupin’s Q1FY23 performance was disappointing on profitability front. It reported its worst-ever EBITDA margin of 6.2% (I-Sec: 7.3%) due to restructuring in the US as well as continuous impact of inflation on raw materials and freight. US revenue sharply declined to US$121mn (I-Sec: 180mn) vs US$172/181mn YoY/QoQ on ~US$40-50mn one-time impact of restructuring, inventory write-offs and withdrawal of products.

Lupin Ltd. has an average target of 2329.44 from 9 brokers.

Lupin Ltd.

05 Aug 2022

2095.70

4.28%

Cost optimization coupled with new launches to help improve margins

Hold: Lupin Ltd.

Recommendation Target

KRChoksey

Lupin continues to post results below expectations. The company reported a 3.9% YoY (-3.6% QoQ) decline in revenue to INR 37,438 mn in Q1FY23. It was far lower than the INR 42,740 mn of revenue we anticipated for the quarter. The underperformance vs. the estimates was largely due to a 28.0%, 17.0%, and 19.0% lower revenue in the US, India, and the Rest of the World (RoW), respectively than anticipated.